Opinion: Longer HIV treatment supplies can support better long term adherence

Opinion: Longer HIV treatment supplies can support better long term adherence

One of the biggest challenges now facing South Africa’s HIV response is how to support many more people living with HIV to engage or re-engage and then stay on treatment. One way to make it easier for people living with HIV to adhere to treatment is to provide a longer supply of medicines, argues Ndivhuwo Rambau & Simphiwe Xaba.

Read More

Why broadly neutralising antibodies might be the next big thing in HIV

Why broadly neutralising antibodies might be the next big thing in HIV

We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks down the science.

Read More

Health in 2021: Spotlight’s top 12 questions

Health in 2021: Spotlight’s top 12 questions

While COVID-19 will continue to make headlines for some time, 2021 will also be a critical year for healthcare reforms in South Africa and for various aspects of the country’s HIV and TB response. These are Spotlight’s top 12 healthcare questions for the year.

Read More

U=U: We should put people living with HIV at the centre of HIV prevention efforts

U=U: We should put people living with HIV at the centre of HIV prevention efforts

The U=U campaign is based on a simple message – an undetectable viral load in people living with HIV equals an untransmissible virus. The U=U campaign, argues Mandisa Dukashe, has the power to motivate people living with HIV to adhere to ARVs, achieve viral suppression, and subsequently lead long and healthy lives while preventing HIV transmission to sexual partners and their babies.

Read More